Indivior Pharmaceuticals, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235
Mailing Address 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235
Phone 804-379-1090
Fiscal Year End 0123
EIN 412520873
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
Material Events
8-K Strategy Change December 15, 2025
High Impact
- INDIVIOR PLC shareholders approved a major corporate reorganization (Scheme of Arrangement).
- INDIVIOR PLC will become a wholly-owned subsidiary of a new parent company, Indivior Pharmaceuticals, Inc.
Insider Trading
BUY 5 insiders
5 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.